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 Conclusions: We report an inverse association between 
MPOD and increasing age. Longitudinal data in a larger co-
hort of participants are required to satisfactorily investigate 
the relationship between the optical density of this pigment 
and age, and with risk for development and/or progression 
of AMD. This pilot study represents a first step in this endea-
vour.  Copyright © 2010 S. Karger AG, Basel 
 Introduction 
 Age-related macular degeneration (AMD) is the ad-
vanced form of age-related maculopathy (ARM), and is 
the leading cause of blindness in people over 50 years of 
age in the developed world  [1, 2] . The number of adults 
registered blind as a result of AMD in industrialized 
countries continues to rise, primarily due to increasing 
longevity  [3, 4] . Beyond its inevitable impact on the indi-
vidual sufferer, AMD poses a growing socioeconomic 
challenge to modern society  [5–7] .
 Three dietary carotenoids, lutein, zeaxanthin and 
 meso -zeaxanthin, accumulate at the macula, where they 
are collectively referred to as macular pigment (MP). Lu-
tein and zeaxanthin are present in many foods, whereas 
 Key Words 
 Age-related macular degeneration   Irish Longitudinal 
Study on Ageing   Macular pigment optical density 
 Abstract 
 Purpose: The 3 carotenoids lutein, zeaxanthin, and  meso -
zeaxanthin, which account for the ‘yellow spot’ at the macu-
la and which are referred to as macular pigment (MP), are 
believed to play a role in visual function and protect against 
age-related macular degeneration (AMD) via their optical 
and antioxidant properties. This study was undertaken to 
compare MP optical density (MPOD) in a population aged 
 1 50 years with MPOD values from a normative database of 
subjects aged 18–60 years.  Methods: Seventy-nine subjects 
were recruited into this pilot study (The Irish Longitudinal 
Study on Ageing-TILDA). MPOD was measured using hetero-
chromatic flicker photometry. Retinal fundus photographs, 
lifestyle data and general health data, were also obtained. 
 Results: The mean  8 SD age of the 79 subjects recruited into 
this study was 65  8 11 years. There was a moderate, but sta-
tistically significant, age-related decline in MPOD at 0.5° in 
the TILDA data (r = –0.251, p = 0.045), which remained upon 
merging with a normative database of an additional 462 
 subjects aged between 18 and 67 years (r = –0.179, p = 0.000). 
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 meso -zeaxanthin is not found in a conventional diet, al-
though it is found in certain types of seafood  [8, 9] . In 
recent years, the anatomic, biochemical and optical prop-
erties of MP have provoked interest in its putative protec-
tion for ARM  [10] .
 The prevalence, incidence and progression of ARM 
have been shown to rise exponentially with increasing 
age  [11, 12] . The free radical theory of ageing is consistent 
with the notion that oxidative stress contributes to age-
related disorders, including ARM  [10]. Given that MP is 
an antioxidant present in the macula, and that ARM is an 
age-related eye disease, MP’s association with age is of 
particular interest.
 To date, studies that have reported on the relationship 
between age and MP have been inconsistent due to the dif-
fering methodologies used and differences in sample size 
( table 1 ). However, the largest study to date to investigate 
this relationship across an appropriate age distribution 
(i.e. 20–60 years) has found a modest, but statistically sig-
nificant, age-related decline in MP levels  [13] ; however, in 
that study, the oldest subject recruited was 60 years of age.
 The Irish Longitudinal Study on Ageing (TILDA) is a 
prospective cohort study led by Trinity College Dublin 
aimed at providing valid and reliable data relating to old-
er people and ageing in Ireland. It will describe the social, 
economic and health status of older Irish adults and try 
to identify the factors that influence healthy ageing. 
 TILDA plans to recruit a nationally representative sample 
of a minimum of 8,000 participants aged 50 years and 
over, with detailed clinical assessments taking place in 3 
waves. Interviews will take place on a 2-yearly basis with 
a comprehensive health assessment at baseline and every 
4 years thereafter.
 The Macular Pigment Research Group (MPRG) at the 
Waterford Institute of Technology (www.wit.ie/mprg) is 
collaborating with TILDA, and has designed a study 
which is primarily aimed at answering the following 
question: does the amount of MP in an eye protect against 
the commonest cause of blind registration in the western 
world? To answer this question, we propose to measure 
MP levels in TILDA participants at baseline, and again at 
years 4 and 8, and correlate the findings with prevalence 
and incidence of AMD. In this way, and uniquely, this 
collaborative approach will be able to determine whether 
baseline and serial MP levels relate to ultimate risk of de-
veloping AMD. Such a finding could possibly defer the 
onset of the condition. Also, a finding that retinal nutri-
tional status relates to the risk for developing AMD will 
have major implications for health policy planners and 
health care providers over the coming years.
 In this paper, we present baseline data from the TILDA 
pilot study phase 1 population, thus allowing us to com-
pare macular pigment optical density (MPOD) in a pop-
ulation aged  1 50 years with values from a normative da-
tabase (subjects aged 18–60 years).
 Methods 
 Subjects 
 The sample for this pilot study was selected using the updated 
RANSAM sampling system developed by the Economic and So-
cial Research Institute [14]. 
 The sampling frame on which this system is based is the Irish 
Geodirectory, a comprehensive and up-to-date listing and map-
ping of all residential addresses in the Republic of Ireland com-
piled by Ordnance Survey Ireland. The target area for the sample 
comprised Dublin City and the county of Dun Laoghaire-Rath-
down.
 Addresses were randomly selected within this area by means 
of a 3-stage process, incorporating proportionate stratification of 
the primary sampling units (geographical units containing at 
least 500 addresses) by socio-economic status (percent in profes-
sional/managerial occupations and per cent with third level edu-
cation), age structure (percent of population aged 50 or over), and 
geographical location. The sample is, therefore, a probability sam-
ple of addresses, where each address has a probability of selection 
proportionate to the percentage of adults aged 50 or over in the 
electoral division in which it is located.
 Nineteen clusters of 40 addresses were selected, giving an ini-
tial sample of 760 addresses. Each address was visited by a field-
worker and one (randomly selected) household member aged 50 
or over was selected as primary respondent for the survey.  This 
person’s spouse (of any age) was also selected for interview. A total 
of 443 addresses were found to be ineligible (dwelling vacant or 
did not contain a person aged 50 or over), leaving 317 valid ad-
dresses. Within these households, a total of 143 respondents com-
pleted an interview in their home. All 143 respondents were in-
vited to attend Trinity College Dublin for a full health assessment, 
of which, 79 accepted, and their data is presented in this paper.
 This study was approved by the research ethics committee of 
Trinity College Dublin, and subjects were required to sign an in-
formed consent document prior to participation. All experimen-
tal procedures adhered to the tenets of the Declaration of Hel-
sinki. Inclusion criteria for participation in this study were age 50 
years or older, and being resident in the Republic of Ireland. In-
stitutionalized people were excluded from recruitment.
 Of particular interest to the macular assessment part of the 
TILDA investigation, the following information was recorded for 
each subject: demographic details; general health status and med-
ication use; family history of AMD; personal smoking history. 
The examination included: visual acuity (LogMAR); body mass 
index [BMI (calculated as kg/m 2 )]; MPOD measurement by het-
erochromatic flicker photometry (HFP; using the Macular Met-
rics Densitometer TM , see below); undilated fundus photography, 
using a non-mydriatic NIDEK NM100 Type D camera.
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 Measurement of Macular Pigment Optical Density Using 
Customized HFP in TILDA Subjects 
 MPOD was measured using the Macular Metrics Densitom-
eter by HFP (Providence, R.l., USA). The device was modified 
specifically for the TILDA trial from the one originally described 
by Wooten et al. in 1999  [15] . Corrected distance visual acuity of 
at least 6/18 was an inclusion criteria for MP measurement (note, 
only one of the 79 subjects was excluded from testing based on this 
requirement). The eye with better vision was chosen for measure-
ment. Of the 79 subjects recruited into the pilot study, 64 subjects 
were able to complete full MPOD assessment at 0.5° of eccentric-
ity. Reasons for subjects not being able to complete full MPOD 
Table 1. P revious studies which reported on the relationship between age and MP levels
Reference Technique Test
stimulus
Parafoveal
stimuli
(eccentricity)
Sample
number
Age range,
years
Age effect Correlation
coefficient
p
Werner, 1987 [$$] HFP 1° 5° 50 10–90 decline –0.21 n.s.
Hammond, 2000 [22] HFP 1° 4° 217 18–90 decline –0.14 <0.05
Ciulla, 2001 [21] HFP 1° 4° 280 18–50 none – n.s.
Delori, 2001 [$$] HFP 0.8° 5.5° 30 15–80 none – n.s.
Beatty, 2001 [37] HFP 0.95° 6° 46 21–81 decline –0.48 <0.05
Mellerio, 2002 [23] HFP 1° 5° 124 18–84 none –0.06 n.s.
Nolan, 2004 [34] HFP 1° 5° 100 22–60 decline –0.359 <0.01
Neelam, 2004 [$$] HFP 1° 5° 125 20–60 decline –0.181 <0.05
Ciulla, 2004 [$$] HFP 1° 4° 390 18–88 none 0.04 n.s.
Bernstein, 2004 [$$] HFP 1.5° 8° 40 18–61 decline –0.279 <0.05
Liew, 2005 [$$] HFP 1° 5° 150 18–50 none – n.s.
Trieschmann, 2006 [$$] AF 1° 6° 108 51–87 decline – 0.17
Nolan, 2007 [13] HFP 1° 5° 800 20–60 decline –0.286 <0.01
Iannacone, 2007 [$$] HFP 1° 7° 222 69–86 decline –0.026 >0.05
Richer, 2007 [$$] HFP 1° 7° 90 – none – –
Nolan, 2007 [29] HFP 0.5° 7° 59 19–57 decline –0.252 <0.05
van der Veen, 2009 [$$] HFP 0.5° 8° 26 22–64 increase 0.083 <0.1
Kilbride, 1989 [$$] Ref. 7 – decline – –
Delori, 2001 [$$] Ref. 159 15–80 increase – –
Chen, 2001 [$$] Ref. 54 20–84 none – –
Berendschot, 2002 [$$] Ref. 435 60–91 increase 0.15 –
Brockmans, 2002 [$$] Ref. 376 18–75 none 0.035 n.s.
Wustemeyer, 2003 [$$] Ref. 109 16–76 decline –0.44 <0.01
Berendschot, 2004 [$$] Ref. 138 18–76 increase 0.14 –
Zagers, 2004 [$$] Ref. 38 18–64 none 0.058 –
Berendschot, 2005 [25] Ref. 134 18–70 none 0.05 n.s.
Berendschot, 2005 [25] Ref. 133 19–70 increase 0.13 n.s.
Berendschot, 2005 [25] Ref. 52 18–70 none 0.03 n.s.
Berendschot, 2005 [25] Ref. 52 19–70 increase 0.16 n.s.
Berendschot, 2005 [25] Ref. 53 19–70 decline –0.22 n.s.
Delori, 2001 [$$] AF 159 15–80 increase – –
Wustemeyer, 2003 [$$] AF 109 16–76 none 0.03 n.s.
Liew, 2005 [$$] AF 150 18–50 increase 0.17 <0.05
Berendschot, 2005 [25] AF 53 18–70 decline –0.08 n.s.
Gellermann, 2002 [$$] RS 140 21–84 decline –0.664 <0.01
Bernstein, 2004 [$$] RS 40 18–61 decline –0.467 <0.01
Neelam, 2004 [$$] RS 125 20–60 decline –0.433 <0.01
Bone, 1998 [$$] HPLC 87 3–95 none – n.s.
Handelman, 1998 [$$] HPLC 16 1 week to 81 none – n.s.
Bone, 2001 [$$] HPLC 56 58–98 increase 0.34 0.01
AF = Autofluorescence; HFP = heterochromatic flicker photometry; HPLC = high-performance liquid chromatography; RS = Ra-
man spectroscopy; Ref. = reflectance.   
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assessment can be summarized as follows: too poor fixation, too 
poor visual acuity, not able to follow instructions, and retinal pa-
thology.
 In order to measure MPOD, the subject views a stimulus that 
alternates between a wavelength band absorbed by MP and one 
that is not. The radiance of the wavelength band absorbed by MP 
is adjusted in order to minimize the subjects’ perception of flick-
er. The range of alternation rates where flicker is not perceived is 
called the null zone. Primarily because of inter-individual differ-
ences in temporal (e.g. flicker) sensitivity, it is optimal to custom-
ize the HFP task for each subject by selecting the alternation rate 
to achieve a null zone and a precise setting. This has been termed 
as customized HFP  [16] .
 The first methodological consideration when using custom-
ized HFP is selecting the appropriate flicker rate. Selecting the 
best flicker rate for each subject enables one to accommodate the 
variation in flicker sensitivity due to factors such as age and dis-
ease  [17, 18] . If differences among subjects in flicker sensitivity are 
not accounted for (i.e. a fixed flicker frequency is used), then a 
subject with low flicker sensitivity (i.e. low critical flicker fusion 
frequency) will most likely experience a large null flicker zone. 
Although the subject may be able to complete the task by elimi-
nating flicker from the test target, the settings are likely to be vari-
able, and subjects may exhibit systematic bias toward one end of 
the null range, resulting in either over- or underestimation of 
MPOD. Alternatively, a subject with a high critical flicker fusion 
frequency may not be able to eliminate flicker from the test target, 
which would make the task difficult to complete. Given that the 
MP investigation part of the TILDA study is only one of many 
parameters under investigation, we were aware of time con-
straints and therefore developed a ‘bracketing’ protocol (de-
scribed below) to allow us to obtain quick, but accurate and cus-
tomized, MPOD values. The sampling target used is a 1° diameter 
disk with 5 min fixation point at the centre. The reference target 
is a 2° diameter disk located 7° nasally with reference to a 5 min 
red fixation point. The background is a 5° disk generated by a 
light-emitting diode (460 nm with 20 nm half pass). Predicted 
optimal HFP flicker frequencies were estimated in order to fa-
cilitate good subject performance and reduce measurement error. 
To achieve this, we used an age-guided algorithm to estimate op-
timal HFP flicker frequencies for both the measurements per-
formed (i.e. the measurement locus at 0.5° and reference locus at 
7°; see below and  table 2 ). This algorithm was informed by many 
years’ experience with the Densitometer at several different labo-
ratories. If the subject reports that there is no null flicker zone, the 
flicker frequency is increased by 2 Hz and the examiner proceed-
ed with macular pigment measurement. This step was repeated if 
necessary.
 The second methodological consideration involves a test stim-
ulus configuration in which the radiances of the 2 alternating 
components are inverse-yoked. In other words, when the blue 
component is adjusted to be more intense, the luminance of the 
green component is commensurately decreased, and vice versa. 
This procedure keeps the brightness of the test stimulus relative-
ly constant. This approach is regarded as an improvement because 
some subjects find changes in brightness distracting when they 
perform the task.
 As mentioned above, the procedure used in the present study 
has been termed as a ‘bracketing’ procedure and was developed 
specifically for the TILDA investigation. This procedure was de-
veloped by members of the Macular Pigment Research Group, 
Waterford, Ireland (J.M.N. and E.C.) and Prof. Wooten of Brown 
University, USA (inventor of the Densitometer), and is described 
below.
 A description of the first part of the test (i.e. fovea, 0.5°) is 
achieved using diagrams, to familiarize the subject with the task 
ahead. The examiner selects the target required to measure 
MPOD at 0.5° (i.e. 1° stimulus) using an accompanying standard 
operating procedure developed for this device. The subject is in-
structed to place his/her test eye (the eye with best visual acuity, 
or else their right eye if visual acuity is equal in both eyes) at the 
viewing eyepiece and the investigator ensures that the tilt of the 
main unit allows comfortable viewing for the subject. The appro-
priate flicker frequency is set for the subject’s age ( table 2 ). The 
examiner sets the radiance dial all the way to the left (i.e. lowest 
blue light intensity). The examiner then pushes a button that elec-
tronically, smoothly and continuously alters the blue/green ratio 
until the subject reports that there is no flicker. The radiance val-
ue obtained is recorded and this same procedure is repeated on 2 
more occasions (3 in total) and recorded in the MPOD log form. 
The examiner sets the radiance dial all the way to the right (i.e. 
highest blue light intensity) and repeats the test 3 times as above. 
Again, the radiance values obtained are recorded in the MPOD 
log form. This completes the first part of the measurement (6 ra-
diance values obtained in total, 3 approaching from the lowest 
blue light intensity and 3 approaching from highest blue light in-
tensity).
 Then, a description of the second part of the measurement 
(parafovea, 7°), using diagrams, is given to the subject by the 
trained TILDA technician. The examiner selects the target and 
fixation point required to measure MPOD at 7° using the accom-
panying standard operating procedure developed for this method 
and the procedure is repeated for this target arrangement as de-
scribed above for the 0.5° measurement. All radiance values ob-
tained (12 in total) are then inputted into the MPOD calculator, 
and an MPOD value at 0.5° is generated for that subject. It should 
be noted that previous investigations into the spatial profile have 
shown a secondary peak that occurs between 0.5° and 1° retinal 
eccentricity in some subjects  [19, 20] ; however, it is important to 
note that the value at 0.5° captures about 95% of the variance of 
the entire MP distribution.
 Previous models of the Densitometer (and most other similar 
devices) control the blue/green energy ratio with a rotary knob. 
Thus, the subject (if using self adjustment) or the experimenter (if 
using bracketing) turn the knob until the desired point of no-
flicker is reached. This works well for most subjects. However, 
Table 2.  Frequency settings used to estimate optimal HFP flicker 
frequencies, by age, for both foveal and parafoveal measurements 
when using the Densitometer
Age Flicker frequency at 0.5° Flicker frequency at 7°
50–60 14 9
61–70 13 8
71–80 12 7
81+ 11 6
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some are prone to adjust the knob much too slowly. Others, on the 
other hand, make their adjustments too quickly. In the bracketing 
procedure, there are individual differences in the way different 
experimenters control the knob. The current version of the Den-
sitometer avoids these potential sources of variability by substi-
tuting the knob with 2 push buttons: one button when depressed 
and held down causes the blue/green ratio to increase, whereas the 
other causes the blue/green ratio to decrease. Unlike a subject or 
experimenter turning a knob, the rate of blue/green change is con-
trolled entirely by the Densitometer’s electronics and was deter-
mined to be optimal (neither too fast or too slow) at 7 s for a sweep 
from one extreme to the other of the blue/green ratio. Preliminary 
studies have shown that this new procedure not only removes the 
aforementioned variability, but the task is qualitatively easier for 
the subjects.
 Statistical Analysis 
 The statistical software package SPSS (version 15) was used for 
statistical and graphical analysis. In addition, the software pack-
age Sigma plot (version 5) was used for some graphical analysis.
 All variables investigated exhibited a typical normal distribu-
tion. Means  8 SDs are presented in the text. Pearson correlation 
coefficients were calculated to investigate bivariate relationships. 
The significance between group differences was determined by 
1-way ANOVA or independent samples t test, depending on the 
analysis in question. We used the 5% level of significance through-
out our analysis.
 Results 
 Demographics and Variables of Relevance to AMD 
 The mean  8 SD age of the 79 subjects recruited into 
the TILDA pilot I study was 65  8 11 years. Twenty-nine 
of the subjects were male and 50 were female. The mean 
 8 SD BMI of the study group was 28  8 6. Of the 72 sub-
jects that reported their smoking habits, 39 reported that 
they smoked cigarettes, cigars, cigarillos or a pipe daily 
for a period of at least 1 year during their lifetime, and 33 
subjects reported that they had not. Of the 70 subjects 
that reported presence or absence of a family history of 
AMD in a first degree relative (i.e. parent or sibling), 9 
(12.9%) reported a positive family history of AMD, 
whereas 61 (87.1%) reported no known family history of 
AMD. The mean  8 SD MPOD at 0.5° of eccentricity for 
the TILDA pilot I study group was 0.23  8 0.17.
 AMD Prevalence in Study Group 
 Undilated retinal fundus photographs were obtained 
(non-mydriatic NIDEK NM100 Type D camera) on both 
eyes of all subjects recruited into the study. Of the 158 
eyes photographed, 123 pictures were deemed of suffi-
cient quality for retinological assessment with respect to 
the presence or absence of AMD by a retinologist (S.B.). 
It is perhaps unsurprising that 22% of photographs were 
of insufficient quality, given the impact of age-related mi-
osis and lens opacity on a study population with this age 
profile, and given that this was a pilot study. Of the 123 
eyes suitable for assessment, 29 eyes (24%) exhibited signs 
of early AMD (i.e. soft drusen, hyper- and/or hypo-pig-
mentary changes). In terms of subjects, 17 (28%) of the 61 
subjects whose photographs were suitable for grading had 
evidence of early disease (as above), with bilateral disease 
evident in 12 (70%) of these subjects. Of the photographs 
upon which comment could be reliably made, no eyes ex-
hibited signs of advanced AMD.
 The large percentage (22%) of retinal photographs that 
were deemed of insufficient quality for retinal assessment 
in this pilot was an important learning outcome from the 
study. Indeed, the TILDA research teams have now taken 
appropriate measures to address this issue. For example, 
collaboration between the Retinal Reading Center, Uni-
versity of Wisconsin, and the TILDA research team has 
now been established, and will include: quality control of 
AMD grading and implementation of standard operating 
procedures and training and certifying the TILDA nurs-
es (to optimize the number of ‘gradable images’ com-
pared to the results presented here).
 MPOD with Respect to Variables Relevant to AMD 
 MPOD and Age 
 There was a moderate, but statistically significant, 
age-related decline in MPOD at 0.5° (r = –0.251, p = 0.045; 
 fig. 1 ). Also, using a normative database of an additional 
462 subjects, aged between 18 and 67 years (data previ-
ously collected and archived by the MPRG using the same 
measuring device as that used in this study) allowed for 
further, and more detailed (greater age spread for com-
parison), investigation of the relationship between MPOD 
and age. Upon merging the databases, the significant in-
verse relationship between age and MPOD remained
(r = –0.179, p = 0.000;  fig. 2 ).
 Reporting the data in terms of MPOD change per age 
decade, we see a significant stepwise reduction in MPOD 
(ANOVA; p = 0.000;  fig. 3 ).
 MPOD and Cigarette Smoking 
 The 39 subjects who reported that they smoked ciga-
rettes, cigars, cigarillos or a pipe daily for a period of at 
least 1 year during their lifetime had significantly lower 
average MPOD values when compared to the 33 subjects 
who reported that they had not (mean  8 SD MPOD at 
0.5° = 0.18  8 0.14 and 0.28  8 0.19, respectively;  fig. 4 ).
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 MPOD and Sex 
 Females had significantly higher MPOD values when 
compared to their male counterparts (mean  8 SD MPOD 
at 0.5° = 0.27  8 0.17 and 0.18  8 0.15, respectively, p = 
0.032).
 MPOD and BMI 
 There was no significant relationship found between 
MPOD and BMI in the TILDA study group (r = –0.26,
p = 0.836).
 MPOD and Its Relationship with Risk Factors for 
AMD as Assessed by Multiple Linear Regression 
Analysis 
 Multiple linear regression analysis was performed to 
analyze the relationship between MPOD and the follow-
ing known and suggested risk factors for AMD: age; sex; 
smoking habits; family history of early AMD, and BMI. 
Statistically non-significant variables were then removed, 
one by one, using the 5% level of significance as the crite-
rion for removal. The regression model eventually ob-
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 Fig. 1. Age-related decline in MPOD for TILDA subjects (n = 64). 
 Fig. 3. Age-related decline in MPOD for 521 subjects (per decade). 
Values presented = mean  8 SD MPOD (per decade). 
 Fig. 2. Age-related decline in MPOD for 521 Irish subjects. 
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Fig. 4. MPOD and smoking habits.
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tained explains about 11% of the variation in MP, with the 
variable age and smoking habits remaining significant 
independent predictors of MP (p  ! 0.05, for both).
 MPOD with Respect to Early AMD Prevalence 
 Both MPOD measurement and retinal assessment 
were successfully completed in 64 of the 79 subjects re-
cruited into the study. Twelve of the 17 (70%) subjects 
with early AMD were able to complete the test for MPOD 
measurement, whereas 52 of the 62 (84%) subjects with 
no signs of AMD were able to complete the test for MPOD 
measurement. Mean  8 SD MPOD in subjects with no 
signs of AMD was significantly higher when compared 
to subjects with early stage AMD (mean MPOD at 0.5° = 
0.25  8 0.17 and 0.14  8 0.13, respectively;  fig. 5 ).
 Discussion 
 TILDA represents a unique opportunity to investigate 
the prevalence and incidence of AMD, as well as the risk 
factors for and impact of this condition in a longitudinal 
fashion, in a naturally representative sample of at least 
8,000 participants.
 This pilot study reports on MPOD in an ageing ran-
domly selected sample of the Irish population (TILDA 
pilot phase I). Mean MPOD in this ageing adult popula-
tion was 0.23, which is low when compared to different 
study populations across all ages (18–87, years inclusive) 
 [13, 21–25] . Although optimal MP values have yet to be 
established, there is a growing body of evidence in sup-
port of the view that MP protects against AMD via its 
antioxidant and short-wavelength filtering properties 
 [10, 26, 27] . This evidence is primarily available from ob-
servational and supplementation studies  [13, 28–35] . For 
a critical review of the scientific literature on this topic, 
see the recent publication by Loane et al. in 2008  [26] .
 There are numerous risk factors for AMD, and it has 
been established that age, cigarette smoking and a family 
history of AMD are the most important and undisputed. 
Of the risk factors that were investigated in the TILDA 
pilot study, increasing age and smoking habits (2 of the 3 
established risk factors for AMD) were independently, 
and significantly, associated with a relative lack of MP. No 
meaningful comment can be made with regards to fam-
ily history of AMD, as this data was self-reported and is 
therefore of limited value, especially when one considers 
that all subjects enrolled were  1 50 years of age and there-
fore their parents probably did not enjoy the longevity 
seen today and associated with the current epidemic of 
AMD.
 The age-related decline in MPOD and the relative lack 
of MP in association with tobacco use are consistent with 
previous findings by our research group, and are in sup-
port of the hypothesis that a relative lack of MP is associ-
ated with risk for AMD  [13] , but are not in agreement 
with data reported from the ‘Carotenoids in Age-Related 
Eye Disease Study – CAREDS’ investigation which mea-
sured MPOD in 1,698 women aged 53–86 years  [36] . Pos-
sible explanations for the outcome discrepancies between 
these studies may be differences in the sample popula-
tions studied, the fact that CAREDS included female sub-
jects only, and differences in dietary and lifestyle habits 
between the populations studied.
 The age-related decline in MPOD observed here rep-
resents an association between the most universal risk 
factor for AMD and a relative lack of the macular carot-
enoids, and is consistent with the view that the increasing 
vulnerability of the ageing macula to AMD may be at-
tributable, at least in part, to a parallel and age-related 
decline in the optical density of MP at the central retina. 
The observed age-related drop in MP may be attributable 
to excessive depletion, or inadequate uptake, of the mac-
ular carotenoids in association with increasing age. A de-
pletion of MP with age would be consistent with excessive 
utilization of the macular carotenoids in response to the 
age-related increase in oxidant load, but could also be at-
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tributable to age-related changes in dietary intake, ab-
sorption, transport in serum, and/or capture by retinal 
tissue of these carotenoids  [13, 37, 38] .
 It should be emphasized that our observations are as-
sociative only, as are all the published data investigating 
the relationship between age and MPOD. Indeed, ad-
dressing this issue by analysing serial MPOD measure-
ments in subjects over time is a key goal of the collabora-
tive research between the MPRG and TILDA, and the 
subject of future work. Nevertheless, the data presented 
here represent the first analysis of MPOD values in sub-
jects randomly selected according to best practice in 
terms of epidemiologic study design, where a validated 
technique (refined for elderly subjects) of measuring the 
optical density of MP was used, and where a large norma-
tive database of MP values (assessed using the same tech-
nique) of a similar but younger Irish population was read-
ily available for comparison.
 Not only do the TILDA pilot data exhibit an age-relat-
ed decline in MPOD in subjects over 50 years, the ob-
served and modest, but statistically significant, age-relat-
ed decline in MPOD remained when we merged the data 
with a larger database with a wider age spread (n = 541, 
aged 18–89 years in total, additional data collected by the 
MPRG using the same measuring device as the one used 
in this study). Indeed, comparing the oldest age group 
available (aged 70 years or more) to the youngest age 
group available (aged 18–30 years), we see a mean differ-
ence in MPOD of 0.23 optical density units (p = 0.000). It 
is also important to note that, while the literature is con-
flicting with respect to the relationship between age and 
MP ( table 1 ), of the 17 published studies that used HFP to 
measure MPOD and report on its association with age, 10 
report an age-related decline in MPOD (7 of which were 
statistically significant), 6 report no age effect in MPOD, 
and only 1 study reported an age-related increase in 
MPOD.
 Other interesting observations, which have emanated 
from this pilot study, include the prevalence of early 
AMD (28%) in a randomly selected sample of Irish sub-
jects over 50 years of age and the statistically significant 
relative lack of MP seen in subjects who displayed early 
signs of AMD. This latter finding is consistent with a pre-
vious report by Beatty et al.  [39] and is also consistent 
with the hypothesis that a relative lack of MP is associ-
ated with disease. However, and again, this observation 
remains associative only, and causality cannot be in-
ferred.
 In conclusion, we report an association between de-
clining MPOD and increasing age. Ultimately, however, 
longitudinal data in a larger cohort of participants are 
required to satisfactorily investigate the relationship 
 between the optical density of this pigment and age,
and with risk for development and/or progression of 
AMD. This pilot study represents a first step in this en-
deavour. 
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